Cargando…

Contrasting Trends of Primary Liver Cancer Mortality in Chinese Mongol and Non-Mongol

BACKGROUND: This study aims to investigate the temporal trend as well as the burden of primary liver cancer among Mongol and non-Mongol in China. MATERIALS AND METHODS: The registered data from up to 20 monitoring points in the periods of 2008 to 2015 in Inner Mongolia were used to calculate and mod...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wen-Qiang, Gao, Xiaoyu, Gao, Liqun, Ma, Yujia, Sun, Dejun, Sun, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850897/
https://www.ncbi.nlm.nih.gov/pubmed/34582643
http://dx.doi.org/10.31557/APJCP.2021.22.9.2757
_version_ 1784652704543408128
author He, Wen-Qiang
Gao, Xiaoyu
Gao, Liqun
Ma, Yujia
Sun, Dejun
Sun, Juan
author_facet He, Wen-Qiang
Gao, Xiaoyu
Gao, Liqun
Ma, Yujia
Sun, Dejun
Sun, Juan
author_sort He, Wen-Qiang
collection PubMed
description BACKGROUND: This study aims to investigate the temporal trend as well as the burden of primary liver cancer among Mongol and non-Mongol in China. MATERIALS AND METHODS: The registered data from up to 20 monitoring points in the periods of 2008 to 2015 in Inner Mongolia were used to calculate and model the trend of liver cancer among Mongol and non-Mongol using log-linear regression. Logistic regression was used to characterise the risk of liver cancer by using hospitalization records from 2008 to 2017. RESULTS: Over the study period, significant reduction of liver cancer mortality was found among non-Mongol population (4.8/100,000 from 23.7/100,000 to 18.9/100,000, p=0.04), while the increase of liver cancer mortality was observed among the Mongolian population (8.4/100,000 from 10.7/100,000 to 19.1/100,000, p=0.02), particularly the Mongol from East (25.5/100,000 from 11.2/100,000 to 36.7/100,000, p=0.005). Comparing to the non-Mongol patients with primary liver cancer, the Mongolian patients were more likely to be from East Inner Mongolia (aOR=3.65, 95% CI:2.75-4.87) and those residing in urban area (aOR=2.11, 95%CI: 1.55-2.91). In 2015, a total of 3056 primary liver cancer deaths could be converted if the four known risk factors (HBV, Hepatitis C Virus, alcohol consumption and smoking) could be prevented. HBV remained to be the leading risk factor of liver cancer (PAF=56%, contributing to 2616 deaths) with the highest among the Mongol from East (PAF=65.1%, contributing to 763 deaths). CONCLUSION: The continuing increase of primary liver cancer among Mongol suggested further interventions were needed to combat its burden.
format Online
Article
Text
id pubmed-8850897
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-88508972022-02-24 Contrasting Trends of Primary Liver Cancer Mortality in Chinese Mongol and Non-Mongol He, Wen-Qiang Gao, Xiaoyu Gao, Liqun Ma, Yujia Sun, Dejun Sun, Juan Asian Pac J Cancer Prev Research Article BACKGROUND: This study aims to investigate the temporal trend as well as the burden of primary liver cancer among Mongol and non-Mongol in China. MATERIALS AND METHODS: The registered data from up to 20 monitoring points in the periods of 2008 to 2015 in Inner Mongolia were used to calculate and model the trend of liver cancer among Mongol and non-Mongol using log-linear regression. Logistic regression was used to characterise the risk of liver cancer by using hospitalization records from 2008 to 2017. RESULTS: Over the study period, significant reduction of liver cancer mortality was found among non-Mongol population (4.8/100,000 from 23.7/100,000 to 18.9/100,000, p=0.04), while the increase of liver cancer mortality was observed among the Mongolian population (8.4/100,000 from 10.7/100,000 to 19.1/100,000, p=0.02), particularly the Mongol from East (25.5/100,000 from 11.2/100,000 to 36.7/100,000, p=0.005). Comparing to the non-Mongol patients with primary liver cancer, the Mongolian patients were more likely to be from East Inner Mongolia (aOR=3.65, 95% CI:2.75-4.87) and those residing in urban area (aOR=2.11, 95%CI: 1.55-2.91). In 2015, a total of 3056 primary liver cancer deaths could be converted if the four known risk factors (HBV, Hepatitis C Virus, alcohol consumption and smoking) could be prevented. HBV remained to be the leading risk factor of liver cancer (PAF=56%, contributing to 2616 deaths) with the highest among the Mongol from East (PAF=65.1%, contributing to 763 deaths). CONCLUSION: The continuing increase of primary liver cancer among Mongol suggested further interventions were needed to combat its burden. West Asia Organization for Cancer Prevention 2021-09 /pmc/articles/PMC8850897/ /pubmed/34582643 http://dx.doi.org/10.31557/APJCP.2021.22.9.2757 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
He, Wen-Qiang
Gao, Xiaoyu
Gao, Liqun
Ma, Yujia
Sun, Dejun
Sun, Juan
Contrasting Trends of Primary Liver Cancer Mortality in Chinese Mongol and Non-Mongol
title Contrasting Trends of Primary Liver Cancer Mortality in Chinese Mongol and Non-Mongol
title_full Contrasting Trends of Primary Liver Cancer Mortality in Chinese Mongol and Non-Mongol
title_fullStr Contrasting Trends of Primary Liver Cancer Mortality in Chinese Mongol and Non-Mongol
title_full_unstemmed Contrasting Trends of Primary Liver Cancer Mortality in Chinese Mongol and Non-Mongol
title_short Contrasting Trends of Primary Liver Cancer Mortality in Chinese Mongol and Non-Mongol
title_sort contrasting trends of primary liver cancer mortality in chinese mongol and non-mongol
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850897/
https://www.ncbi.nlm.nih.gov/pubmed/34582643
http://dx.doi.org/10.31557/APJCP.2021.22.9.2757
work_keys_str_mv AT hewenqiang contrastingtrendsofprimarylivercancermortalityinchinesemongolandnonmongol
AT gaoxiaoyu contrastingtrendsofprimarylivercancermortalityinchinesemongolandnonmongol
AT gaoliqun contrastingtrendsofprimarylivercancermortalityinchinesemongolandnonmongol
AT mayujia contrastingtrendsofprimarylivercancermortalityinchinesemongolandnonmongol
AT sundejun contrastingtrendsofprimarylivercancermortalityinchinesemongolandnonmongol
AT sunjuan contrastingtrendsofprimarylivercancermortalityinchinesemongolandnonmongol